BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, Kahan BC, Luengo-Fernandez R, Pepperell JCT, Evison MD, Holme J, Al-Aloul M, Psallidas I, Lim WS, Blyth KG, Roberts ME, Cox G, Downer NJ, Herre J, Sivasothy P, Menzies D, Munavvar M, Kyi MM, Ahmed L, West AG, Harrison RN, Prudon B, Hettiarachchi G, Chakrabarti B, Kavidasan A, Sutton BP, Zahan-Evans NJ, Quaddy JL, Edey AJ, Clive AO, Walker SP, Little MHR, Mei XW, Harvey JE, Hooper CE, Davies HE, Slade M, Sivier M, Miller RF, Rahman NM, Maskell NA. Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial. JAMA 2020;323:60-9. [PMID: 31804680 DOI: 10.1001/jama.2019.19997] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 21.0] [Reference Citation Analysis]
Number Citing Articles
1 Chiang KY, Ho JC, Chong P, Tam TC, Lam DC, Ip MS, Lee YG, Lui MM. Role of early definitive management for newly diagnosed malignant pleural effusion related to lung cancer. Respirology 2020;25:1167-73. [PMID: 32249488 DOI: 10.1111/resp.13812] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Mytinger A, Taylor T, Gershman E, Shojaee S. Pleural Disease Management: Manometry-guided Thoracentesis, Optimal Drainage Regimen of Indwelling Pleural Catheters, and Talc Poudrage versus Slurry for Malignant Pleural Effusion. Am J Respir Crit Care Med 2020;202:448-50. [PMID: 32421351 DOI: 10.1164/rccm.202003-0599RR] [Reference Citation Analysis]
3 Feller‐kopman D. Interventional pulmonology: There is no going back, only forward. Respirology 2020;25:909-10. [DOI: 10.1111/resp.13896] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Banka R, George V, Rahman NM. Multidisciplinary approaches to the management of malignant pleural effusions: a guide for the clinician. Expert Rev Respir Med 2020;14:1009-18. [PMID: 32634337 DOI: 10.1080/17476348.2020.1793672] [Reference Citation Analysis]
5 Chaddha U, Agrawal A, Bhavani SV, Sivertsen K, Donington DJ, Ferguson MK, Murgu S. Thoracic ultrasound as a predictor of pleurodesis success at the time of indwelling pleural catheter removal. Respirology 2021;26:249-54. [PMID: 32929838 DOI: 10.1111/resp.13937] [Reference Citation Analysis]
6 Ferreiro L, Suárez-Antelo J, Álvarez-Dobaño JM, Toubes ME, Riveiro V, Valdés L. Malignant Pleural Effusion: Diagnosis and Management. Can Respir J 2020;2020:2950751. [PMID: 33273991 DOI: 10.1155/2020/2950751] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Lima TA, Coler RA, Laub GW, Sexton S, Curtin L, Laub KM, Alvarez NJ. A mechanism for improved talc pleurodesis via foam delivery. Drug Deliv 2021;28:733-40. [PMID: 33827326 DOI: 10.1080/10717544.2021.1895910] [Reference Citation Analysis]
8 Campion E, Mallah SI, Azhar M, O'Keeffe D, Hameed A. A multidirectional two-tube method for chemical pleurodesis could improve distribution of the sclerosing agent within the pleural cavity - A pilot study. Ann Med Surg (Lond) 2021;68:102697. [PMID: 34408869 DOI: 10.1016/j.amsu.2021.102697] [Reference Citation Analysis]
9 Bedawi EO, Guinde J, Rahman NM, Astoul P. Advances in pleural infection and malignancy. Eur Respir Rev 2021;30:200002. [PMID: 33650525 DOI: 10.1183/16000617.0002-2020] [Reference Citation Analysis]
10 Agrawal A, Murgu S. Multimodal approach to the management of malignant pleural effusions: role of thoracoscopy with pleurodesis and tunneled indwelling pleural catheters. J Thorac Dis 2020;12:2803-11. [PMID: 32642188 DOI: 10.21037/jtd.2020.03.57] [Reference Citation Analysis]
11 Cohodes EM, McCauley S, Gee DG. Parental Buffering of Stress in the Time of COVID-19: Family-Level Factors May Moderate the Association Between Pandemic-Related Stress and Youth Symptomatology. Res Child Adolesc Psychopathol 2021;49:935-48. [PMID: 33591457 DOI: 10.1007/s10802-020-00732-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhang W, Zhao YL, Li SJ, Zhao YN, Guo NN, Liu B. Complications of thoracoscopic talc insufflation for the treatment of malignant pleural effusions: a meta-analysis. J Cardiothorac Surg 2021;16:125. [PMID: 33947423 DOI: 10.1186/s13019-021-01475-1] [Reference Citation Analysis]
13 Dipper A, Jones HE, Bhatnagar R, Preston NJ, Maskell N, Clive AO. Interventions for the management of malignant pleural effusions: a network meta-analysis. Cochrane Database Syst Rev 2020;4:CD010529. [PMID: 32315458 DOI: 10.1002/14651858.CD010529.pub3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
14 Molina S, Martinez-Zayas G, Sainz PV, Leung CH, Li L, Grosu HB, Adachi R, Ost DE. Breast and Lung Effusion Survival Score Models: Improving Survival Prediction in Patients With Malignant Pleural Effusion and Metastasis. Chest 2021;160:1075-94. [PMID: 33852918 DOI: 10.1016/j.chest.2021.03.059] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]